van Grinsven Janneke, van Vugt Jeroen L A, Gharbharan Arvind, Bollen Thomas L, Besselink Marc G, van Santvoort Hjalmar C, van Eijck Casper H J, Boerma Djamila
Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands.
St Antonius Hospital, Nieuwegein, The Netherlands.
J Gastrointest Surg. 2017 Jun;21(6):1000-1008. doi: 10.1007/s11605-016-3352-3. Epub 2017 Mar 15.
Identification of patients with necrotizing pancreatitis at high risk for a complicated course could facilitate clinical decision-making. In multiple diseases, several parameters of body composition are associated with impaired outcome, but studies in necrotizing pancreatitis are lacking.
A post hoc analysis was performed in a national prospective cohort of 639 patients with necrotizing pancreatitis. Skeletal muscle mass, skeletal muscle density, and visceral adipose tissue were measured at the third lumbar vertebra level (L3) on contrast-enhanced computed tomography (CT) within 10 days after initial admission and 1 month thereafter.
In total, 496 of 639 patients (78%) were included. Overall mortality rate was 14.5%. Skeletal muscle mass and density and visceral adipose tissue on first CT were not independently associated with in-hospital mortality. However, low skeletal muscle density was independently associated with increased mortality in patients ≥65 years (OR 2.54 (95%CI 1.12-5.84, P = 0.028). Skeletal muscle mass and density significantly decreased within 1 month, for both males and females, with a median relative loss of muscle mass of 12.9 and 10.2% (both P < 0.001), respectively. Skeletal muscle density decreased with 7.2 and 7.5% (both P < 0.001) for males and females, respectively. A skeletal muscle density decrease of ≥10% in 1 month was independently associated with in-hospital mortality: OR 5.87 (95%CI 2.09-16.50, P = 0.001).
First CT-assessed body composition parameters do not correlate with in-hospital mortality in patients with necrotizing pancreatitis. Loss of skeletal muscle density ≥10% within the first month after initial admission, however, is significantly associated with increased mortality in these patients.
识别坏死性胰腺炎患者中发生复杂病程的高风险患者有助于临床决策。在多种疾病中,身体成分的几个参数与不良预后相关,但坏死性胰腺炎方面的研究较少。
对639例坏死性胰腺炎患者的全国前瞻性队列进行事后分析。在初次入院后10天内及之后1个月,于增强计算机断层扫描(CT)上在第三腰椎水平(L3)测量骨骼肌质量、骨骼肌密度和内脏脂肪组织。
639例患者中共有496例(78%)纳入研究。总体死亡率为14.5%。首次CT检查时的骨骼肌质量、密度和内脏脂肪组织与住院死亡率无独立相关性。然而,骨骼肌密度低与≥65岁患者死亡率增加独立相关(比值比2.54(95%置信区间1.12 - 5.84,P = 0.028))。男性和女性的骨骼肌质量和密度在1个月内均显著下降,骨骼肌质量的中位相对损失分别为12.9%和10.2%(均P < 0.001)。男性和女性的骨骼肌密度分别下降7.2%和7.5%(均P < 0.001)。1个月内骨骼肌密度下降≥10%与住院死亡率独立相关:比值比5.87(95%置信区间2.09 - 16.50,P = 0.001)。
首次CT评估的身体成分参数与坏死性胰腺炎患者的住院死亡率无关。然而,初次入院后第一个月内骨骼肌密度损失≥10%与这些患者死亡率增加显著相关。